Skip to main content
TipRanks
Go Ultimate75% OFF

Jong Joseph Kim Insider Profile

46 Followers

Jong Joseph Kim, CEO, Director at Inovio Pharmaceuticals, holds 2.35M shares in Inovio Pharmaceuticals (Ticker: INO).

Jong Joseph Kim's Trading History

INO
Inovio Pharmaceuticals
Mar 14, 2022CEO, DirectorUninformative Buy321.00K$3.35M
INO
Insider Shares: 2.35M (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 14, 2022Uninformative Buy$321.00K99,689$3.22―
Mar 09, 2022Uninformative Buy$148.52K45,558$3.26―
Mar 01, 2022Uninformative Buy$156.88K48,722$3.22―
Mar 12, 2021Uninformative Buy$685.38K64,842$10.57―
Mar 09, 2021Uninformative Buy$777.48K85,503$9.09―

You May Also Like

Jong Joseph Kim insider profile FAQ

What is the percentage of profitable transactions made by Jong Joseph Kim?
The percentage of profitable transactions made by Jong Joseph Kim is 71%.
What is the average return per transaction made by Jong Joseph Kim?
The average return per transaction made by Jong Joseph Kim is 38.80%.
What stocks does Jong Joseph Kim hold?
Jong Joseph Kim holds: INO stocks.
What was Jong Joseph Kim’s latest transaction?
Jong Joseph Kim’s latest transaction was an Uninformative Buy of $321.00K.
What was Jong Joseph Kim's most profitable transaction?
Jong Joseph Kim’s most profitable transaction was an Informative Buy of INO stock on January 13, 2020. The return on the trade was 178.70%.
What is Jong Joseph Kim's role in Inovio Pharmaceuticals?
Jong Joseph Kim's role in Inovio Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.